Improving lipid-lowering treatment and cardiovascular risk management in primary care: findings from an audit and

Michelangelo Rottura1, Selene Francesca Anna Drago2, Antonino Molonia1

  • 1Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

Insights

An audit and feedback intervention improved lipid management for high-risk cardiovascular patients in primary care. This led to better data recording and increased achievement of low-density lipoprotein cholesterol (LDL-C) targets.

Area of Science:

  • Cardiology
  • Primary Care Medicine
  • Health Services Research

Background:

  • Cardiovascular diseases are a leading global cause of death.
  • Low-density lipoprotein cholesterol (LDL-C) is crucial in atherogenesis.
  • Many high-risk patients do not meet LDL-C targets in primary care.

Purpose of the Study:

  • To assess if audit and feedback (A&F) improves lipid management in high and very-high cardiovascular risk (HCVR) patients.
  • To evaluate the impact of A&F on data completeness and LDL-C target attainment.

Main Methods:

  • Retrospective-prospective observational study of general practitioners (GPs).
  • Active GPs received A&F intervention (training, feedback reports); controls provided data only.
  • Data extracted from electronic medical records across three 18-month periods (T0, T1, T2).

Main Results:

  • Active GPs showed significant improvements in recording LDL-C, HbA1c, BMI, smoking, and alcohol consumption.
  • LDL-C target attainment rose from 6.1% to 14.5% in active GPs, surpassing controls (8.7%).
  • Lipid-lowering therapy use increased from 48.9% to 61.3%, with higher intensity therapy use also rising.

Conclusions:

  • Audit and feedback, with multidisciplinary support, enhances data completeness.
  • The intervention effectively improved lipid management for high-risk patients in primary care settings.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
603
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.9K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
866
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
441
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
702
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
590